https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-01-01 / Int J Hyperthermia 2021;38(1):144-151
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-01-01 / Int J Hyperthermia 2021;38(1):144-1512021-01-01 00:00:002023-01-31 16:01:23Beneficial effects of modulated electro-hyperthermia during neoadjuvant treatment for locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-12-28 / Pharmacol Res 2021 Feb;164:105374
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-12-28 / Pharmacol Res 2021 Feb;164:1053742020-12-28 00:00:002020-12-28 00:00:00Dendritic cell vaccine therapy for colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-12-08 / PeerJ 2020;8:e9761
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-12-08 / PeerJ 2020;8:e97612020-12-08 00:00:002020-12-08 00:00:00Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-08-13 / Immunotherapy 2020 Aug;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-08-13 / Immunotherapy 2020 Aug;2020-08-13 00:00:002020-08-13 00:00:00The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-06-29 / Cancer Cell Int. 2020;20:278
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-06-29 / Cancer Cell Int. 2020;20:2782020-06-29 00:00:002020-06-29 00:00:00Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-05-22 / Immunotargets Ther 2020;9:95-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-05-22 / Immunotargets Ther 2020;9:95-1042020-05-22 00:00:002020-05-22 00:00:00Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2020-02-09 / Neoplasma 2020 May;67(3):677-683
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2020-02-09 / Neoplasma 2020 May;67(3):677-6832020-02-09 00:00:002020-02-09 00:00:00Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-10-03 / Cancers (Basel) 2019 Oct;11(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-10-03 / Cancers (Basel) 2019 Oct;11(10)2019-10-03 00:00:002019-10-03 00:00:00Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-2154
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-21542019-08-26 00:00:002020-08-26 14:20:49Application of Newcastle disease virus in the treatment of colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-06-10 / Cancer Med 2019 Jun;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-06-10 / Cancer Med 2019 Jun;2019-06-10 00:00:002019-06-10 00:00:00Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro
